Results 261 to 270 of about 5,796,978 (304)
Some of the next articles are maybe not open access.
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Rebecca L. Siegel +2 more
exaly
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Heather Parsons +2 more
exaly
Tumor necrosis factor: receptors and inhibitors.
Cancer cells (Cold Spring Harbor, N.Y. : 1989), 1991Tumor necrosis factor (TNF) is a highly potent pleiotropic response modifier in inflammatory and immunologic host defense reactions. It can also be toxic to cells and elicit toxic systemic reactions, as evinced by certain pathophysiologic conditions that are initiated or aggravated by an excess of TNF.
H, Loetscher, M, Steinmetz, W, Lesslauer
openaire +1 more source
Tumor necrosis factor receptor superfamily.
Journal of inflammation, 1997Tumor necrosis factor (TNF) is a powerful cytokine which is involved in the immune and pro-inflammatory response. The TNF receptors (TNF-R1 and TNF-R2) are the sole mediators of TNF signaling. The receptors consist of a disulfide rich domain which recognizes TNF, a transmembrane helix, and a cytoplasmic domain.
J H, Naismith, S R, Sprang
openaire +1 more source
Gastroenteropancreatic Neuroendocrine Tumors
Ca-A Cancer Journal for Clinicians, 2018Jonathan Strosberg, Mauro Cives
exaly
BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth
Journal of Experimental Medicine, 1999Jeffrey L. Browning +2 more
exaly
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Journal of Experimental Medicine, 1986D M Stern, P P Nawroth
exaly